- Drug Pipelines
- March 2025
- 60 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Drug Pipelines
- April 2024
- 50 Pages
Global
From €1432EUR$1,500USD£1,199GBP
- Report
- May 2024
- 138 Pages
Global
From €6203EUR$6,499USD£5,197GBP
- Report
- May 2024
- 131 Pages
Global
From €6203EUR$6,499USD£5,197GBP
- Report
- May 2024
- 135 Pages
Global
From €6203EUR$6,499USD£5,197GBP
- Drug Pipelines
- December 2024
- 60 Pages
Global
From €1432EUR$1,500USD£1,199GBP
- Clinical Trials
- November 2024
- 60 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Clinical Trials
- August 2024
- 60 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Report
- June 2024
- 200 Pages
Global
From €7587EUR$7,950USD£6,357GBP
- Report
- June 2024
- 200 Pages
Global
From €7587EUR$7,950USD£6,357GBP
- Report
- June 2024
- 200 Pages
Global
From €7587EUR$7,950USD£6,357GBP
- Report
- June 2024
- 200 Pages
Global
From €7587EUR$7,950USD£6,357GBP
- Report
- June 2024
- 200 Pages
Global
From €7587EUR$7,950USD£6,357GBP
- Report
- May 2024
- 134 Pages
From €6203EUR$6,499USD£5,197GBP
- Clinical Trials
- April 2024
- 40 Pages
From €1193EUR$1,250USD£1,000GBP
- Report
- August 2022
Global
From €754EUR$790USD£632GBP
- Report
- August 2022
Global
From €754EUR$790USD£632GBP
- Report
- August 2024
- 89 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- September 2023
- 112 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- August 2022
- 111 Pages
Global
From €1909EUR$2,000USD£1,599GBP

The Fever Drug market is a subset of the Infectious Diseases Drugs market, which focuses on the treatment of fever-related illnesses. Fever Drugs are used to reduce the body temperature of a patient, and can be administered orally, intravenously, or topically. Common Fever Drugs include acetaminophen, ibuprofen, and aspirin. These drugs are used to treat a variety of illnesses, including the common cold, flu, and other viral infections. Fever Drugs are also used to reduce the symptoms of more serious illnesses, such as malaria, meningitis, and sepsis.
The Fever Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck, Sanofi, Novartis, Johnson & Johnson, and Bayer. Show Less Read more